The trial did not show a large enough effect. If you were waiting for this treatment, talk about other options with your gastroenterologist.
Email alerts
Hear about it when research moves forward
A new treatment enters trials, another is stopped, an approval comes through in Europe or the US: get it by email, once a month.
One letter a month, two levels
Read as far as you like: the essentials in plain words at the top, the detail for professionals below.
- At the top, the essentials in plain words, for patients and their families: what is reaching pharmacies, the results that matter, awaited treatments that have been stopped, without jargon.
- Below, going further, for healthcare professionals and the curious: every change in detail, with the trial stage, patient numbers, time frames, EMA and FDA decisions, and sources.
- Nothing else: no advertising, your address is never sold.
Get the letter
What does an item look like?
Primary endpoint not met at 12 weeks. Stage and status updated in the Radar, with links to the registry and the announcement.
Made-up examples, to show the tone of the letter.